Dora Graciela Tombari is a prominent inventor based in Buenos Aires, Argentina. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of new crystalline forms of zoledronic acid. With a total of 5 patents to her name, her work has the potential to impact the pharmaceutical industry significantly.

Latest Patents

Among her latest patents, Tombari has developed a new crystalline form of zoledronic acid, characterized by its X-ray diffractogram and spatial atomic distribution in the red crystalline. This innovative form also includes curves of thermal analysis. Additionally, she has outlined a method to obtain this crystalline form, which involves the synthesis of the corresponding acid and the pharmaceutical composition that this crystalline form comprises. Her work in this area demonstrates her commitment to advancing pharmaceutical science.

Career Highlights

Throughout her career, Tombari has worked with notable companies such as Gador S.A. and Gador Sociedad Anonima. Her experience in these organizations has allowed her to refine her skills and contribute to significant advancements in pharmaceutical formulations.

Collaborations

Tombari has collaborated with esteemed colleagues, including Adriana Vechhioli and Rafael Alberto Labriola. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Dora Graciela Tombari's contributions to pharmaceutical chemistry, particularly through her patents on zoledronic acid, highlight her role as a key innovator in the field. Her work continues to pave the way for advancements in drug formulation and delivery.

This text is generated by artificial intelligence and may not be accurate.